A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning

Immunotherapy by using immune checkpoint inhibitors (ICI) has dramatically improved the treatment options in various cancers, increasing survival rates for treated patients. Nevertheless, there are heterogeneous response rates to ICI among different cancer types, and even in the context of patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Polano, Maurizio, Chierici, Marco, Dal Bo, Michele, Gentilini, Davide, Di Cintio, Federica, Baboci, Lorena, Gibbs, David L., Furlanello, Cesare, Toffoli, Giuseppe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6827166/
https://ncbi.nlm.nih.gov/pubmed/31618839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101562
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller